These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


63 related items for PubMed ID: 15494162

  • 41. Ataxin-2: a powerful RNA-binding protein.
    Li L, Wang M, Huang L, Zheng X, Wang L, Miao H.
    Discov Oncol; 2024 Jul 22; 15(1):298. PubMed ID: 39039334
    [Abstract] [Full Text] [Related]

  • 42. The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.
    Costa RG, Conceição A, Matos CA, Nóbrega C.
    Cell Death Dis; 2024 Jun 14; 15(6):415. PubMed ID: 38877004
    [Abstract] [Full Text] [Related]

  • 43. A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases.
    Johnson SL, Tsou WL, Prifti MV, Harris AL, Todi SV.
    Front Mol Neurosci; 2022 Jun 14; 15():974167. PubMed ID: 36187346
    [Abstract] [Full Text] [Related]

  • 44. The Multiple Faces of Spinocerebellar Ataxia type 2.
    Antenora A, Rinaldi C, Roca A, Pane C, Lieto M, Saccà F, Peluso S, De Michele G, Filla A.
    Ann Clin Transl Neurol; 2017 Sep 14; 4(9):687-695. PubMed ID: 28904990
    [Abstract] [Full Text] [Related]

  • 45. Motor Dysfunctions and Neuropathology in Mouse Models of Spinocerebellar Ataxia Type 2: A Comprehensive Review.
    Alves-Cruzeiro JM, Mendonça L, Pereira de Almeida L, Nóbrega C.
    Front Neurosci; 2016 Sep 14; 10():572. PubMed ID: 28018166
    [Abstract] [Full Text] [Related]

  • 46. Drosophila ataxin-2 gene encodes two differentially expressed isoforms and its function in larval fat body is crucial for development of peripheral tissues.
    Vianna MC, Poleto DC, Gomes PF, Valente V, Paçó-Larson ML.
    FEBS Open Bio; 2016 Nov 14; 6(11):1040-1053. PubMed ID: 27833845
    [Abstract] [Full Text] [Related]

  • 47. Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.
    Magaña JJ, Velázquez-Pérez L, Cisneros B.
    Mol Neurobiol; 2013 Feb 14; 47(1):90-104. PubMed ID: 22996397
    [Abstract] [Full Text] [Related]

  • 48. Experimental and computational analysis of polyglutamine-mediated cytotoxicity.
    Tang MY, Proctor CJ, Woulfe J, Gray DA.
    PLoS Comput Biol; 2010 Sep 23; 6(9):. PubMed ID: 20885783
    [Abstract] [Full Text] [Related]

  • 49. Spinocerebellar ataxia 2 (SCA2).
    Lastres-Becker I, Rüb U, Auburger G.
    Cerebellum; 2008 Sep 23; 7(2):115-24. PubMed ID: 18418684
    [Abstract] [Full Text] [Related]

  • 50. Different ataxin-2 antibodies display different immunoreactive profiles.
    Turnbull VJ, Storey E, Tarlac V, Walsh R, Stefani D, Clark R, Kelly L.
    Brain Res; 2004 Nov 19; 1027(1-2):103-16. PubMed ID: 15494162
    [Abstract] [Full Text] [Related]

  • 51. Ataxin-2 associates with rough endoplasmic reticulum.
    van de Loo S, Eich F, Nonis D, Auburger G, Nowock J.
    Exp Neurol; 2009 Jan 19; 215(1):110-8. PubMed ID: 18973756
    [Abstract] [Full Text] [Related]

  • 52. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
    Pimpinelli F, Lehmann S, Maridonneau-Parini I.
    Eur J Neurosci; 2005 Apr 19; 21(8):2063-72. PubMed ID: 15869502
    [Abstract] [Full Text] [Related]

  • 53. Apparent presence of Ser133-phosphorylated cyclic AMP response element binding protein (pCREB) in brain mitochondria is due to cross-reactivity of pCREB antibodies with pyruvate dehydrogenase.
    Pláteník J, Balcar VJ, Yoneda Y, Mioduszewska B, Buchal R, Hynek R, Kilianek L, Kuramoto N, Wilczynski G, Ogita K, Nakamura Y, Kaczmarek L.
    J Neurochem; 2005 Dec 19; 95(5):1446-60. PubMed ID: 16219034
    [Abstract] [Full Text] [Related]

  • 54. Partial resistance of ataxin-2-containing olivary and pontine neurons to axotomy-induced degeneration.
    Viscomi MT, Florenzano F, Amadio S, Bernardi G, Molinari M.
    Brain Res Bull; 2005 Aug 15; 66(3):212-21. PubMed ID: 16023918
    [Abstract] [Full Text] [Related]

  • 55. Different ataxin-2 antibodies display different immunoreactive profiles.
    Turnbull VJ, Storey E, Tarlac V, Walsh R, Stefani D, Clark R, Kelly L.
    Brain Res; 2004 Nov 19; 1027(1-2):103-16. PubMed ID: 15494162
    [Abstract] [Full Text] [Related]

  • 56. Ataxin-2 associates with rough endoplasmic reticulum.
    van de Loo S, Eich F, Nonis D, Auburger G, Nowock J.
    Exp Neurol; 2009 Jan 19; 215(1):110-8. PubMed ID: 18973756
    [Abstract] [Full Text] [Related]

  • 57. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
    Pimpinelli F, Lehmann S, Maridonneau-Parini I.
    Eur J Neurosci; 2005 Apr 19; 21(8):2063-72. PubMed ID: 15869502
    [Abstract] [Full Text] [Related]

  • 58. Apparent presence of Ser133-phosphorylated cyclic AMP response element binding protein (pCREB) in brain mitochondria is due to cross-reactivity of pCREB antibodies with pyruvate dehydrogenase.
    Pláteník J, Balcar VJ, Yoneda Y, Mioduszewska B, Buchal R, Hynek R, Kilianek L, Kuramoto N, Wilczynski G, Ogita K, Nakamura Y, Kaczmarek L.
    J Neurochem; 2005 Dec 19; 95(5):1446-60. PubMed ID: 16219034
    [Abstract] [Full Text] [Related]

  • 59. Partial resistance of ataxin-2-containing olivary and pontine neurons to axotomy-induced degeneration.
    Viscomi MT, Florenzano F, Amadio S, Bernardi G, Molinari M.
    Brain Res Bull; 2005 Aug 15; 66(3):212-21. PubMed ID: 16023918
    [Abstract] [Full Text] [Related]

  • 60. Different ataxin-2 antibodies display different immunoreactive profiles.
    Turnbull VJ, Storey E, Tarlac V, Walsh R, Stefani D, Clark R, Kelly L.
    Brain Res; 2004 Nov 19; 1027(1-2):103-16. PubMed ID: 15494162
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.